place in Nice, France, and brought together leading experts in the field as

they discussed several topics. In this podcast series, you will hear the

latest updates in acute myeloid leukemia (AML) and acute lymphoblastic

leukemia (ALL) and gain an insight into the sessions that took place at this

year’s meeting.

The first session from iwAL focused on the standard of care in AML in

2022. In this podcast, Mark Levis, MD, PhD, Johns Hopkins Sidney Kimmel

Comprehensive Cancer Center, Baltimore, MD, Eunice Wang, MD, Roswell

Park Comprehensive Cancer Center, Buffalo, NY, Jessica Altman, MD,

Robert H. Lurie Comprehensive Cancer Center, Northwestern University,

Chicago, IL, and Charles Craddock, CBE, FRCP, FRCPath, DPhil, University

of Birmingham, Birmingham, UK, discuss and debate the current standard

of care in AML in 2022, commenting on the role of transplantation and

novel agents, as well as treatment approaches for relapsed FLT3-mutated

disease.